GHRP-2 is a synthetic growth hormone secretagogue that has been found to bind to the ghrelin/growth hormone secretagogue receptor. Its effects have been studied in research trials, which have shown that it can improve muscle growth, regulate the immune system, and enhance sleep cycles.
Additionally, GHRP-2 has been found to be orally bio-active, and is used as a test peptide for assessing growth hormone deficiency and secondary adrenal failure. Studies have investigated GHRP-2 in clinical trials for short stature, and ongoing research is exploring its effects on appetite, muscle growth, the immune system, and sleep cycles.
GHRP-2 can stimulate muscle growth by increasing protein deposition and reducing protein degradation, which overcomes growth plateaus that may occur due to factors such as food deprivation, disease, and adverse environmental conditions.
Moreover, GHRP-2 can prevent muscle atrophy by inactivating proteins that control the muscle degradation pathway. GHRP-2 also activates growth hormone and insulin-like growth factor-1 to promote muscle protein deposition, and encourages the development of lean body mass even in challenging conditions.
Additionally, research has shown that GHRP-2 and related peptides can protect heart cells by reducing programmed cell death, and may have specific receptors that can be targeted for drug development. Furthermore, GHRP-2 can stimulate the thymus to produce more T-cells, which are critical for adaptive immunity and fighting off infections.
With age, the thymus function declines, which can lead to various age-related dysfunctions. GHRP-2 has been shown to rejuvenate the thymus, leading to improved immunity.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
GHRP-2, or Growth Hormone Releasing Peptide-2, is a synthetic hexapeptide designed for advanced investigation of growth hormone axis physiology, ghrelin receptor signaling, and downstream metabolic pathways in preclinical and in vitro models. This research-grade peptide is manufactured via chemical synthesis and supplied as a lyophilized powder for precise laboratory protocol design.
As a selective agonist of the growth hormone secretagogue receptor, GHRP-2 has been evaluated in animal and cell systems for its ability to modulate pulsatile growth hormone release, influence IGF-1 linked cascades, and interact with appetite and energy balance signaling. Nordsci GHRP-2 is produced to stringent analytical specifications and is intended exclusively for controlled scientific research. Researchers building broader endocrine study frameworks may also review Nordsci resources on growth hormone secretagogue research models, GH pulse comparison frameworks, and multi-compound peptide stack design when organizing multi-arm studies.
GHRP-2 Research Peptide Specifications:
| Unit Size | 5 or 10mg/vial |
| Unit Quantity | 1 vial |
| Purity (HPLC) | ≥ 99% |
| Peptide Type | Growth Hormone Releasing Peptide-2 |
| Sequence | D-Ala–D-2-Nal–Ala–Trp–D-Phe–Lys–NH2 |
| Molecular Formula | C45H55N9O6 |
| Molecular Weight | ~817.0 g/mol |
| Appearance | Lyophilized white to off-white powder |
| Source | Chemical synthesis |
| Storage Conditions | Store lyophilized GHRP-2 at -20 °C in a dry, dark environment. After reconstitution, keep aliquots refrigerated and use within protocol-defined stability windows. |
| Research Use Only | For laboratory research use only. Not for human consumption, clinical treatment, diagnostic use, or veterinary applications. |
GHRP-2 is a second-generation growth hormone secretagogue that binds to the ghrelin receptor expressed in the pituitary and hypothalamus. In preclinical models, GHRP-2 has been shown to stimulate pulsatile growth hormone release, interact synergistically with growth hormone releasing hormone signaling, and modulate downstream IGF-1 related cascades under controlled conditions.
By acting as a ghrelin mimetic, GHRP-2 enables investigators to probe:
These properties make GHRP-2 a useful tool compound for dissecting the growth hormone axis, evaluating growth hormone secretagogue receptor pharmacology, and comparing different secretagogue classes under standardized assay conditions. Teams planning broader protocol architecture may find added value in Nordsci’s content on secretagogue comparison research and stack sequencing and variable isolation.
Important Research Notice: All mechanistic discussion is derived from animal and in vitro data. GHRP-2 from Nordsci is not approved as a drug or therapy and must never be used for self-administration or any non-research purpose.
Preclinical studies have used GHRP-2 to characterize how growth hormone secretagogue receptor agonism alters growth hormone pulse amplitude, frequency, and total output. Typical research endpoints include serial hormone measurements following controlled exposure, comparative analyses across secretagogue classes, assessment of synergy with GHRH-linked signaling, and receptor desensitization or recovery kinetics with repeated stimulation.
Because growth hormone influences lipolysis, carbohydrate handling, and lean mass accrual in animal models, GHRP-2 is often integrated into broader metabolic research frameworks. Investigators may explore changes in body composition, adipose distribution, lean tissue markers, dietary interactions, glucose tolerance, insulin sensitivity indices, and fasting metabolic panels.
In practice, these designs tend to be most useful when researchers keep endpoint categories clearly separated and interpret GHRP-2 as an upstream endocrine signal modulator rather than a single-outcome compound. Nordsci’s educational articles on weight-related research frameworks and GH-axis and body composition study design align with this type of structure.
Growth hormone related pathways intersect with sleep architecture, recovery capacity, and tissue remodeling in preclinical settings. GHRP-2 can be utilized in research programs to model growth hormone linked contributions to recovery following controlled physical stressors, study the interplay between endocrine pulses and sleep-wake cycles, and examine axis responses under chronic stress or glucocorticoid exposure.
These models are especially useful in programs that want to compare hormone-pattern effects across different physiological stress environments without collapsing all variables into one readout. Investigators refining those datasets often use broader reference material on selective secretagogue signaling and multi-phase stack methodology.
Reconstitution Guidelines for Research Use:
Reconstitute each vial with a suitable sterile laboratory diluent, such as bacteriostatic water or another protocol-approved vehicle, to achieve the desired working concentration for in vitro or animal model use. Concentrations, exposure intervals, and handling windows should be determined by institutional protocols, published literature, and study objectives.
Note: Reconstitution guidance is provided strictly as a high-level research reference. All experimental work must be approved by the relevant institutional animal care and ethics committees and conducted by qualified personnel in appropriately equipped laboratories.
Nordsci GHRP-2 undergoes independent third-party analytical testing to verify identity and purity before release. Each batch is supported by high-performance liquid chromatography purity analysis, mass spectrometry confirmation of molecular weight, and documentation of lot number, production date, and storage recommendations.
COA documentation is available to qualified research institutions for internal recordkeeping, protocol development, and regulatory audits.
GHRP-2 should be sourced only from specialized peptide suppliers that clearly label products for research use, provide detailed analytical documentation, and maintain robust quality standards. Nordsci Peptides focuses on supplying GHRP-2 and complementary growth hormone axis research compounds to professional laboratories and investigators.
Before integrating GHRP-2 into any experimental protocol, research teams should validate:
THIS PRODUCT IS INTENDED FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN CONSUMPTION. NOT INTENDED TO DIAGNOSE, TREAT, CURE, OR PREVENT ANY DISEASE OR CONDITION.
